These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results Terminated 2010-024213-31 Can Vitamin D Replacement Reduce Insulin resistance In South Asians with Vitamin D Deficiency? 2014-01-08 due-trials
Reported results 2011-000284-27 A Randomised Controlled Trial for People with Established Type 2 Diabetes during Ramadan: Liraglutide versus a Sulphonylurea and/or Pioglitazone 2012-12-06 due-trials
Reported results 2011-005545-12 Enhanced Control of Hypertension and Thrombolysis Stroke Trial 2018-09-30 due-trials
Reported results 2012-002422-78 Impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes: an open lable, randomised active-comparator trial. 2017-09-29 due-trials
Ongoing 2014-001992-30 A randomised controlled phase II trial of oral vinorelbine as second line therapy for patients with malignant pleural mesothelioma not-yet-due
Completed, report not yet due 2014-004049-29 Investigating Aspirin and Ticagrelor for the prevention of tumour cell-induced platelet aggregation 2020-01-29 not-yet-due
Reported results 2014-004958-34 Midazolam Measurement and Modelling using Matrix Samplers 2016-10-09 due-trials
Reported results 2015-000172-98 An Open Label Oxygen Enhanced Imaging Biomarker Study to Assess the Role of Fluticasone/Formoterol upon Airway Function in Moderate to Severe Persistent Asthma. 2018-01-31 due-trials
Completed, report not yet due 2015-001594-40 SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation: A randomised double-blind placebo-controlled trial (SEESAW) 2019-07-30 not-yet-due
Ongoing 2015-002094-38 The Effect of an SGLT2 inhibitor on Glucose Flux, Lipolysis and Ketogenesis following insulin withdrawal in people with absolute or relative endogenous insulin deficiency not-yet-due
Reported results 2015-002104-91 A Randomised Controlled Trial for People with Established Type 2 Diabetes during Ramadan: Canagliflozin (Invokana™) vs. standard dual therapy regimen: The ‘Can Do Ramadan’ Study 2018-09-13 due-trials
Reported results 2015-003073-15 HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) 2017-08-07 due-trials
Reported results 2015-003259-24 The Effect of Sildenafil (REVATIO®) on Post Cardiac Surgery Acute Kidney Injury: A Randomised, Placebo-controlled Phase IIb Clinical Trial: The REVAKI-2 Trial 2018-09-20 due-trials
Ongoing 2016-004878-17 The Effect of a SGLT2 inhibitor on Glucose flux, Lipolysis and Exercise in type 2 Diabetes not-yet-due
Reported results 2017-002560-41 A Calcium channel or Angiotensin converting enzyme inhibitor/Angiotensin receptor blocker Regimen to reduce Blood pressure variability in acute ischaemic Stroke (CAARBS): A Feasibility Trial 2019-03-31 due-trials
Ongoing 2017-002998-20 Effectiveness and cost of integrating a protocol with use of liraglutide 3.0mg into an obesity service (STRIVE Study) not-yet-due
Ongoing 2017-003353-41 Mesothelioma Stratified Therapy (MiST): A stratified multi-arm phase IIa clinical trial to enable accelerated evaluation of targeted therapies for relapsed malignant mesothelioma. not-yet-due
Ongoing 2017-004366-10 A Phase 2 Placebo-controlled Double Blinded Study to Assess the Efficacy and Safety of Belimumab in Subjects with Immunoglobulin A Nephropathy (IgAN) not-yet-due
Ongoing 2018-000919-24 A randomised placebo-controlled trial of anti-ST2 in COPD (COPD-ST2OP) not-yet-due
Ongoing 2018-002012-27 A Single Centre, Open-label, Single-group Exploratory Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients with Immunoglobulin A Nephropathy not-yet-due
Ongoing 2018-002076-41 A RANDOMISED CONTROLLED TRIAL OF PRE-SURGERY SODIUM VALPROATE, FOR THE PREVENTION OF ORGAN INJURY IN CARDIAC SURGERY: Val-CARD not-yet-due
Ongoing 2018-003924-35 A Randomised Controlled Trial of Mepolizumab Initiated During Admission to Hospital for a Severe Exacerbation of Eosinophilic COPD not-yet-due
Ongoing 2019-003013-34 Beyond Allergic Th2 Severe Asthma not-yet-due
Ongoing 2019-003764-45 Multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distress. not-yet-due
Ongoing 2019-004041-32 The effect of Canagliflozin 300mg, in subjects without diabetes after bariatric surgery, on glucose homeostasis (The CONTROL Study): A proof-of-concept, randomised, open-label, two period crossover st... not-yet-due